Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136360420> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W3136360420 endingPage "381" @default.
- W3136360420 startingPage "381" @default.
- W3136360420 abstract "Background: Pemetrexed (PEM) is a new-generation multitargeted antifolate agent that has been shown to have broad-spectrum efficacy in a variety of human cancers, including NSCLC and mesothelioma. Dose-limiting hematologic toxicities are among the most serious side effects. PEM nephrotoxicity is well-known, but its occurrence is thought to be rare. Aim was to determine nephrotoxicity induced due to pemetrexed in non-small cell lung cancer patients.Methods: In patients with the NSCLC, we record a retrospective review on PEM- induced renal toxicity. A total of 327 NSCLC patients were treated in our hospital between 2012 and 2019. Of these, 134 patients were diagnosed with 2 or more chemotherapy cycles. 60 of these patients have been diagnosed with combination of antineoplastic drugs based on pemetrexed and platinum. Others were removed from the study and were also required to be tested for other potential causes of renal injury.Results: Suitable statistical tools were used and data was analysed which showed that repeated chemo cycles of pemetrexed leads to the reversible acute kidney injury. With the results from our study we can understand the severity of nephrotoxicity induced with pemetrexed in patients with non-small cell lung cancer. Most of the patients were in the first and second stages of nephrotoxicity and most of them were male. Majority of the patients were also above 40 years of age and also endured more than 4 chemo cycles.Conclusions: It shows that PEM allows longer survival, but acute or chronic kidney failure is the price for this achievement. In conclusion, renal toxicity should be controlled routinely in patients treated with pemetrexed. Before each cycle of pemetrexed, creatinine clearance should be measured. Patients need to be well hydrated during treatment. The patient should also be tested for concomitant medications, and any nephrotoxic symptoms should be reviewed and those drugs removed." @default.
- W3136360420 created "2021-03-29" @default.
- W3136360420 creator A5014792811 @default.
- W3136360420 creator A5018181866 @default.
- W3136360420 creator A5033028545 @default.
- W3136360420 creator A5049870751 @default.
- W3136360420 date "2021-03-22" @default.
- W3136360420 modified "2023-10-18" @default.
- W3136360420 title "A retrospective study on pemetrexed induced nephrotoxicity in non-small cell lung carcinoma patients" @default.
- W3136360420 doi "https://doi.org/10.18203/2319-2003.ijbcp20211019" @default.
- W3136360420 hasPublicationYear "2021" @default.
- W3136360420 type Work @default.
- W3136360420 sameAs 3136360420 @default.
- W3136360420 citedByCount "0" @default.
- W3136360420 crossrefType "journal-article" @default.
- W3136360420 hasAuthorship W3136360420A5014792811 @default.
- W3136360420 hasAuthorship W3136360420A5018181866 @default.
- W3136360420 hasAuthorship W3136360420A5033028545 @default.
- W3136360420 hasAuthorship W3136360420A5049870751 @default.
- W3136360420 hasBestOaLocation W31363604201 @default.
- W3136360420 hasConcept C126189478 @default.
- W3136360420 hasConcept C126322002 @default.
- W3136360420 hasConcept C142724271 @default.
- W3136360420 hasConcept C143998085 @default.
- W3136360420 hasConcept C167135981 @default.
- W3136360420 hasConcept C2776256026 @default.
- W3136360420 hasConcept C2776694085 @default.
- W3136360420 hasConcept C2777240266 @default.
- W3136360420 hasConcept C2777407522 @default.
- W3136360420 hasConcept C2777472916 @default.
- W3136360420 hasConcept C2778239845 @default.
- W3136360420 hasConcept C2780472472 @default.
- W3136360420 hasConcept C29730261 @default.
- W3136360420 hasConcept C71924100 @default.
- W3136360420 hasConceptScore W3136360420C126189478 @default.
- W3136360420 hasConceptScore W3136360420C126322002 @default.
- W3136360420 hasConceptScore W3136360420C142724271 @default.
- W3136360420 hasConceptScore W3136360420C143998085 @default.
- W3136360420 hasConceptScore W3136360420C167135981 @default.
- W3136360420 hasConceptScore W3136360420C2776256026 @default.
- W3136360420 hasConceptScore W3136360420C2776694085 @default.
- W3136360420 hasConceptScore W3136360420C2777240266 @default.
- W3136360420 hasConceptScore W3136360420C2777407522 @default.
- W3136360420 hasConceptScore W3136360420C2777472916 @default.
- W3136360420 hasConceptScore W3136360420C2778239845 @default.
- W3136360420 hasConceptScore W3136360420C2780472472 @default.
- W3136360420 hasConceptScore W3136360420C29730261 @default.
- W3136360420 hasConceptScore W3136360420C71924100 @default.
- W3136360420 hasIssue "4" @default.
- W3136360420 hasLocation W31363604201 @default.
- W3136360420 hasOpenAccess W3136360420 @default.
- W3136360420 hasPrimaryLocation W31363604201 @default.
- W3136360420 hasRelatedWork W2083305999 @default.
- W3136360420 hasRelatedWork W2358450743 @default.
- W3136360420 hasRelatedWork W2381460883 @default.
- W3136360420 hasRelatedWork W2413537020 @default.
- W3136360420 hasRelatedWork W2480785262 @default.
- W3136360420 hasRelatedWork W2591408645 @default.
- W3136360420 hasRelatedWork W2603922820 @default.
- W3136360420 hasRelatedWork W2953220268 @default.
- W3136360420 hasRelatedWork W3032772405 @default.
- W3136360420 hasRelatedWork W3205509964 @default.
- W3136360420 hasVolume "10" @default.
- W3136360420 isParatext "false" @default.
- W3136360420 isRetracted "false" @default.
- W3136360420 magId "3136360420" @default.
- W3136360420 workType "article" @default.